514
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Treatment Outcome of Jaundice and Its Associated Factors Among Neonates Treated in Neonatal Intensive Care Unit of Comprehensive and Specialized Hospitals of Southern Nations Nationalities and Peoples Region, Ethiopia 2022

ORCID Icon, & ORCID Icon
Pages 237-247 | Received 28 Feb 2023, Accepted 19 Jul 2023, Published online: 26 Jul 2023

References

  • American College of Gastroenterology AG. Improving patient care. Neonatal Jaundice; 2022.
  • Bizuneh AD, Alemnew B, Getie A, Wondmieneh A, Gedefaw G. Determinants of neonatal jaundice among neonates admitted to five referral hospitals in Amhara region, Northern Ethiopia: an unmatched case-control study. BMJ Paediatr Open. 2020;4(1):e000830–e. doi:10.1136/bmjpo-2020-000830
  • Mir SE, van der Geest BAM, Been JV. Management of neonatal jaundice in low- and lower-middle-income countries. BMJ Paediatrics Open. 2019;3(1):e000408. doi:10.1136/bmjpo-2018-000408
  • Mitra S, Rennie J. Neonatal jaundice: aetiology, diagnosis and treatment. Br J Hosp Med. 2017;78(12):699–704. doi:10.12968/hmed.2017.78.12.699
  • Amos RC, Jacob H, Leith W. Jaundice in newborn babies under 28 days: NICE guideline 2016 (CG98). Arch Dis Child Educ Pract. 2017;102(4):207–209. doi:10.1136/archdischild-2016-311556
  • Greco C, Arnolda G, Boo NY, et al. Neonatal jaundice in low- and middle-income countries: lessons and future directions from the 2015 Don Ostrow Trieste Yellow Retreat. Neonatology. 2016;110(3):172–180. doi:10.1159/000445708
  • Ullah S, Rahman K, Hedayati M. Hyperbilirubinemia in neonates: types, causes, clinical examinations, preventive measures and treatments: a narrative review article. Iran J Public Health. 2016;45(5):558–568.
  • Olusanya BO, Osibanjo FB, Slusher TM. Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117229. doi:10.1371/journal.pone.0117229
  • Olusanya BO, Ogunlesi TA, Kumar P, et al. Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings. BMC Pediatr. 2015;15(1):1–12. doi:10.1186/s12887-015-0358-z
  • Hyperbilirubinemia Guideline. Dell Children’s Medical Center E-Boc. Hyperbilirubinemia Guideline; 2021:11.
  • Olusanya BO, Teeple S, Kassebaum NJ. The contribution of neonatal jaundice to global child mortality: findings from the GBD 2016 study. Pediatrics. 2018;141(2). doi:10.1542/peds.2017-1471
  • Blencowe H, Vos T, Lee ACC, et al. Estimates of neonatal morbidities and disabilities at regional and global levels for 2010: introduction, methods overview, and relevant findings from the Global Burden of Disease study. Pediatr Res. 2013;74(1):4–16. doi:10.1038/pr.2013.203
  • Bhutani VK, Vilms RJ, Hamerman-Johnson L. Universal bilirubin screening for severe neonatal hyperbilirubinemia. J Perinatol. 2010;30(1):S6–S15. doi:10.1038/jp.2010.98
  • Bhutani VK, Zipursky A, Blencowe H, et al. Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res. 2013;74(1):86–100. doi:10.1038/pr.2013.208
  • Olusanya BO, Imam ZO, Emokpae AA, Iskander IF. Revisiting the criteria for exchange transfusion for severe neonatal hyperbilirubinemia in resource-limited settings. Neonatology. 2016;109(2):97–104. doi:10.1159/000441324
  • Slusher TM, Zamora TG, Appiah D, et al. Burden of severe neonatal jaundice: a systematic review and meta-analysis. BMJ Paediatr Open. 2017;1(1):e000105. doi:10.1136/bmjpo-2017-000105
  • Birhanu MY, Workineh AA, Molla Y, Abebaw E, Arora A, Bazezew Y. Rate and predictors of neonatal jaundice in northwest Ethiopia: prospective cohort study. J Multidiscip Healthc. 2021;14:447–457. doi:10.2147/JMDH.S298034
  • Lake EA, Abera GB, Azeze GA, Gebeyew NA, Demissie BW. Magnitude of neonatal jaundice and its associated factor in neonatal intensive care units of Mekelle City public Hospitals, Northern Ethiopia. Int J Pediatr. 2019;2019:1054943. doi:10.1155/2019/1054943
  • Hyperbilirubinemia AAoPSo. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316. doi:10.1542/peds.114.1.297
  • Olusanya BO, Ogunlesi TA, Slusher TM. Why is kernicterus still a major cause of death and disability in low-income and middle-income countries? Arch Dis Child. 2014;99(12):1117–1121. doi:10.1136/archdischild-2013-305506
  • Al-Lawama M, Badran E, Ala’Elrimawi ABM, Alkhatib H, Alkhatib H. Intravenous Immunoglobulins as adjunct treatment to phototherapy in isoimmune hemolytic disease of the newborn: a retrospective case-control study. J Clin Med Res. 2019;11(11):760. doi:10.14740/jocmr4003
  • Olusanya B, Osibanjo F, Mabogunje C, Slusher T, Olowe S. The burden and management of neonatal jaundice in Nigeria: a scoping review of the literature. Niger J Clin Pract. 2016;19(1):1–17. doi:10.4103/1119-3077.173703
  • Dennery PA. Pharmacological interventions for the treatment of neonatal jaundice. Semin Neonatol. 2002;7(2):111–119. doi:10.1053/siny.2002.0098
  • Slusher TM, Vaucher YE. Management of neonatal jaundice in low- and middle-income countries. Paediatr Int Child Health. 2020;40(1):7–10. doi:10.1080/20469047.2019.1707397
  • Sharma S. Neonatal hyperbilirubinemia: hospital based study in western region, Nepal. Janap J Interdiscip Stud. 2016;5:75–82. doi:10.3126/jjis.v5i0.17841
  • Kumar M, Tripathi S, Singh SN, Anand V. Outcome of neonates with severe hyperbilirubinemia in a tertiary level neonatal unit of North India. Clin Epidemiology Glob Health. 2016;4(2):51–56. doi:10.1016/j.cegh.2015.05.003
  • Shitran RF, Abed MY. Risk factors and outcomes of neonatal jaundice at al-Ramadi teaching hospital for maternity and childhood. Ann Trop Med PH. 2020;23:231. doi:10.36295/ASRO.2020.231228
  • Zhang M, He Y, Tang J, et al. Intensive phototherapy vs. exchange transfusion for the treatment of neonatal hyperbilirubinemia: a multicenter retrospective cohort study. Chin Med J. 2022;135(5):598–605. doi:10.1097/CM9.0000000000001962
  • Zabeen B, Nahar J, Nabi N, et al. Risk factors and outcome of neonatal jaundice in a tertiary hospital. Ibrahim Med Coll J. 2010;4(2):70–73. doi:10.3329/imcj.v4i2.6500
  • Mukoro G, Omekwe D, Kennis B, et al. Survey and management outcome of neonatal jaundice from a developing tertiary health centre, Southern Nigeria. IOSR J Dent Med Sci. 2014;13:35–39. doi:10.9790/0853-13413539
  • Osuorah CD, Ekwochi U, Asinobi IN. Clinical evaluation of severe neonatal Hyperbilirubinaemia in a resource-limited setting: a 4-year longitudinal study in south-East Nigeria. BMC Pediatr. 2018;18(1):1–7. doi:10.1186/s12887-018-1174-z
  • Israel-Aina Y, Omoigberale A. Risk factors for neonatal jaundice in babies presenting at the University of Benin teaching hospital, Benin City. Niger J Paediatr. 2012;39(4):159–163. doi:10.4314/njp.v39i4.2
  • Marzoog AS, Mohammed HN, Habib KD. Effectiveness of conventional phototherapy, intensive phototherapy and exchange transfusion in treating neonatal jaundice at Fatima Al-Zahra Hospital for maternity and children in Baghdad. AL-Kindy Coll Med J. 2020;16(2):25–29. doi:10.47723/kcmj.v16i2.262
  • Meslhy MF, El-Mohsen MM A, Hammad KS, Ahmed HH. Aetiological profile and outcome of jaundiced neonates admitted to Bab Alsharyia university hospital. Al-Azhar Journal of Pediatrics. 2020. doi: 10.21608/azjp.2020.128813.
  • Lakshmi S. Neonatal Hyper Bilirubinemia in Level II NICU And Its Outcome-A Tertiary Care Centre Experience, Hyderabad, India. IOSR J Dent Med Sci. 2017;16(11):12–18. Available from: https://www.iosrjournals.org/iosr-jdms/papers/Vol16-issue11/Version-4/C1611041218.pdf
  • Demtse A, Sebsibie G, Godie Y, Birhan Y, Nesru A. Clinical audit on neonatal care unit structure in five selected governmental hospitals of Addis Ababa, Ethiopia 2019. Int Arch Nurs Health Care. 2020;6:140.
  • Oluwafemi RO, Abiodun MT, Owa JA. Prevalence, risk factors and short-term outcome of babies with Neonatal Jaundice in a secondary facility with free-health services in South-West, Nigeria. Borno Med J. 2019;2019:1–9.
  • Nyangabyaki-Twesigye C, Mworozi E, Namisi C, et al. Prevalence, factors associated and treatment outcome of hyperbilirubinaemia in neonates admitted to St Francis hospital, Nsambya, Uganda: a descriptive study. Afr Health Sci. 2020;20(1):397–405. doi:10.4314/ahs.v20i1.46
  • Demis A, Getie A, Wondmieneh A, Alemnew B, Gedefaw G. Knowledge on neonatal jaundice and its associated factors among mothers in northern Ethiopia: a facility-based cross-sectional study. BMJ Open. 2021;11(3):e044390. doi:10.1136/bmjopen-2020-044390
  • Islam MM, Masud MS. Health care seeking behaviour during pregnancy, delivery and the postnatal period in Bangladesh: assessing the compliance with WHO recommendations. Midwifery. 2018;63:8–16. doi:10.1016/j.midw.2018.04.021
  • Jain A, Singh S, Choudhary A, Jain A, Chouudhary A. Maternal health-care seeking behavior in North India. Fam Med Prim Care Rev. 2017;6(2):265–269. doi:10.4103/2249-4863.219999
  • Onyearugha C, Onyire B, Ugboma H. Neonatal jaundice: prevalence and associated factors as seen in Federal medical centre Abakaliki, Southeast Nigeria. J Clin Med Res. 2011;3(3):40–45.
  • Kafle SP, Bhatta M, Shrestha R, Sitaula S, Koirala N, Koirala A. Outcome of Neonatal Hyperbilirubinemia from a Tertiary Care Hospital in Eastern Nepal: a Cross-sectional Study. J BP Koirala Inst Health Sci. 2021;4(1):37–42. doi:10.3126/jbpkihs.v4i1.36324
  • Rao AK, SaiRam A, Seethamahalakshmi K. Maternal and Child factors associated with Neonatal jaundice influencing the outcome of Phototherapy in Karimnagar district. MRIMS J Health Sci. 2017;5(4):124. doi:10.4103/2321-7006.302553
  • Abdelazeem K, Soliman A, Askar E. Efficacy of intensive phototherapy in management of neonatal hyperbilirubinemia inneonatal unit of assiut university children Hospital. J Neonatal Biol. 2017;6:266.
  • Amin SB, Wang H. Unbound unconjugated hyperbilirubinemia is associated with central apnea in premature infants. J Pediatr. 2015;166(3):571–575. doi:10.1016/j.jpeds.2014.12.003
  • Wang J, Guo G, Li A, Cai W-Q, Wang X, Chen J. Challenges of phototherapy for neonatal hyperbilirubinemia. Exp Ther Med. 2021;21(3):1. doi:10.3892/etm.2020.9464
  • Wang J, Guo G, Li A, Cai W-Q, Wang X. Challenges of phototherapy for neonatal hyperbilirubinemia (Review). Exp Ther Med. 2021;21(3):231. doi:10.3892/etm.2021.9662
  • Wolf MF, Childers J, Gray KD, et al. Exchange transfusion safety and outcomes in neonatal hyperbilirubinemia. J Perinatol. 2020;40(10):1506–1512. doi:10.1038/s41372-020-0642-0
  • Zhang R, Kang W, Zhang X, et al. Outcome Analysis of Severe Hyperbilirubinemia in Neonates Undergoing Exchange Transfusion. Neuropediatrics. 2022;53:257–264. doi:10.1055/s-0041-1742156
  • Qian S, Kumar P, Testai FD. Bilirubin Encephalopathy. Curr Neurol Neurosci Rep. 2022;2022:1–11.